CSF1R and colorectal cancer: This study mainly focused on the tumor infiltrating myeloid cells, and revealed the potential mechanism of immunotherapeutics targeting myeloid cells (anti-CSF1R and anti-CD40 agonism) in mouse models with colorectal cancers (32).